Download presentation
1
Veterans Aging Cohort Study (VACS)
Required: Optional based on other project funding:
2
Now have support through August 2016 for a total of 20 years of follow up in Virtual Cohort and 16 years for VACS 8
3
VACS Cohort and Substudies
Virtual Cohort pos 47,805 neg 99,061 VC/Queri pos neg 70000 VACS 9 pos neg 3962 Exhale pos neg 170 DNA pos neg 900 CVD pos neg117 Biomarkers pos neg 800 Virtual Cohort(VC) comprised of national data. Elements include demographics, diagnostic and procedure codes, labs, pharmacy, vital signs… VACS9 is the 9 site consented patient study with richer data. Includes surveys, adjudicated outcomes for cancer, mi, liver disease, site downloaded data VC limited to patients in 2003 or later. Includes adjudicated MI from IHD Queri Includes Ddimer, IL6, sCD14 3 VACS sites only. Includes GXT, CT and echo data
4
Virtual Cohort (VC) SUBJECTS: 47,805 HIV infected; 99,061 uninfected
All individuals with HIV diagnoses Age, race/ethnicity, region 2:1 matched controls Last updated: September 2014 Next update: Currently in progress SITES: All VA sites BASELINE: 1998 (15 years of follow up) HIV infected veterans at initiation of HIV care Controls selected and followed in same calendar year
5
VACS 9 BASELINE: 2002 (11 years)
CURRENT DATA SOURCES (all VC sources plus) All VA Electronic medical records including text fields Sentinel event records (MI) requested outside VA DNA and tissue bank (subset of 2,300 patients) Self completed surveys (health behaviors, quality of life, symptoms, outside utilization, etc.) every months SUBJECTS: 3,790 HIV infected; 3,962 uninfected Group matched: age, race/ethnicity, and site Last updated October 16, 2013 SITES: Atlanta1, Bronx1, Houston1, Los Angeles1, New York1, Baltimore2, Washington DC2, Pittsburgh3, Dallas4, Nashville5 ** present, present, present, present, present BASELINE: 2002 (11 years)
6
National VACS/COMpAAAS Project Team 2014
7
COMpAAAS Steering Committee
Amy C. Justice, MD, PhD Consortium PI Angela Consorte, Director Administrative Core David Fiellin, MD, Director Alcohol and Behavioral Intervention Core Janet Tate, ScD, MPH, Director Biostatistics Core Cynthia Brandt, MD, MPH, Director Joseph Erdos, MD, PhD, Co-Director Medical Informatics Core Cores (supported by other grants): Directors Cancer Disease: L Park, PhD, MPH & K Sigel, MD Cardiovascular Disease: M Freiberg, MD, MSc Liver Disease: V LoRe, MD & J Tate, ScD, MPH Pulmonary Disease: K Crothers, MD Translational Research: C Rinaldo, MD & M Freiberg, MD, MSc Site PIs: Atlanta: V Marconi, MD Baltimore: M Sajadi, MD Bronx: S Brown, MD Brooklyn/Manhattan: M Simberkoff, MD Dallas: R Bedimo, MD Houston: M Rodriguez-Barradas, MD Los Angeles: M Goetz, MD Nashville: T Hulgan, MD Pittsburgh: A Butt, MD Washington, D.C: C Gibert, MD Workgroups: Directors ART: N Gandhi, MD & J Tate, ScD, MPH Endocrine and Bone Disease: J Womack, APRN, PhD Health Services Research: E Wang, MD & K McGinnis, MS Kidney Disease: F P Wilson, MD Opioids: J Edelman, MD Physical Function and Disability: KA Oursler, MD Polypharmacy: A Justice, MD, PhD & J Edelman, MD Risk Index: A Justice, MD, PhD & J Tate, ScD, MPH Statins: R Bedimo, MD & J Tate, ScD, MPH Uniform Services: V Marconi, MD Scott Braithwaite, MD, MSc, Director Operations Research Core Steering Committee Kendall Bryant, PhD, Director Nancy Day, PhD David Leaf, MD Stephen Maisto, PhD Patrick O’Connor, MD, PhD David Rimland, MD Charles Rinaldo, MD Jeffrey Samet, MD, PhD COMpAAAS
8
Acknowledgements Consortium PI : AC Justice*
Scientific Collaborator (NIAAA): K Bryant Affiliated PIs: S Braithwaite, K Crothers*, R Dubrow, DA Fiellin*, M Freiberg*, V LoRe*, K Kraemer Participating VA Medical Centers: Atlanta (V Marconi*), Baltimore (M Sajadi, R Titanji), Bronx (S Brown, Y Ponomarenko), Dallas (R Bedimo*), Houston (M Rodriguez-Barradas, N Masozera), Los Angeles (M Goetz, D Leaf), Manhattan-Brooklyn (M Simberkoff, D Blumenthal, H Leaf, J Leung), Pittsburgh (A Butt, K Kraemer, E Hoffman), and Washington DC (C Gibert, R Peck) Core and Workgroup Chairs: B Agan, W Becker, C Brandt, J Edelman, N Gandhi, B Gulanski, K McGinnis, KA Oursler, L Park, C Rinaldo, K Sigel, J Tate, E Wang, F P Wilson, J Womack Staff: H Bathulapalli, T Bohan, J Ciarleglio, A Consorte, L Erickson, S Felter, C Frank, K Gordon, J Huston, F Kidwai-Khan, G Koerbel, F Levin, S Shahrir, M Skanderson Major Collaborators: VA Public Health Strategic Healthcare Group, VA Pharmacy Benefits Management, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Yale Center for Interdisciplinary Research on AIDS (CIRA), Center for Health Equity Research and Promotion (CHERP), ART-CC, NA-ACCORD, HIV-Causal Cross Cohort Collaborators: Richard Moore (NA-ACCORD), Jonathan Sterne (ART-CC), Brian Agan (DoD), Miguel Hernan (HIV-Causal) Major Funding by: National Institutes of Health: AHRQ (R01-HS018372), NIAAA (U24-AA020794, U01-AA020790, U01-AA020795, U01-AA020799, U24-AA022001, U24 AA022007, R01-AA023733, R01AA022886, U10 AA completed), NHLBI (R01-HL125032, RO1-HL126555, R01-HL completed, R01-HL completed) , NIAID (U01-A ), NIDA (R01DA035616, R03DA031592), NCI (R01 CA173754) and the Veterans Health Administration Office of Research and Development (VA REA , VA IRR Merit Award) and Office of Academic Affiliations (Medical Informatics Fellowship) *Indicates individual is also the Chair of a Core or Workgroup
9
Acknowledgements Continued
Other Notable Funding: Career Development Awards: Veterans Health Administration: VISN 1 CDA (V1CDA ), HSR&D CDA-2 (08-276); National Institutes of Health: NINR (1K01R013437), NCRR/NCATS (5UL1RR024139), NIDA (1K12DA A1, 8UL1TR000142, 1R03DA031592) COMpAAAS/Veterans Aging Cohort Study, a CHAART Cooperative Agreement, supported by the National Institutes of Health: National Institute on Alcohol Abuse and Alcoholism (U24-AA020794, U01-AA020790, U01-AA020795, U01-AA020799; U10 AA completed) and in kind by the US Department of Veterans Affairs. In addition to grant support from NIAAA, we gratefully acknowledge the scientific contributions of Dr. Kendall Bryant, our scientific collaborator. QR Codes QR Code for VACS QR Code for VACS QR Code for VACS Homepage INDEX CALCULATOR INDEX CALCULATOR- MOBILE APP
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.